winner
- Avenue Therapeutics, Inc. ATXI Shares rose 106.3% to close at $9.15. Avenue Therapeutics recently received official meeting minutes from the FDA regarding a meeting conducted for intravenous tramadol in combination with other opioid analgesics for the treatment of moderate to moderate pain. At the same time, Avenue Therapeutics announced that it would conduct a 1:15 reverse stock split.
- Scienjoy Holding Corporation SJ up 47.9% to close at $2.47 after falling 44% on Monday.
- Sonendo, Inc. SONX gained 42.7% to close at $1.67. Sonendo recently announced a private placement of common stock and pre-funded warrants, raising gross proceeds of $63 million, led by a consortium of new and existing investors.
- X4 Pharmaceuticals, Inc. XFOR rose 40.2% to $1.25 after the company announced data from its phase 1b study evaluating mavorixafor in chronic neutropenia.
- Antelope Enterprise Holdings Limited AEHL rose 37.5% to $0.9320.
- Grove Collaborative Holdings, Inc. GROV Shares rose 35.5% to close at $4.01. Grove Collaborative continued retail expansion by entering thousands more stores.
- InMed Pharmaceuticals Inc. INM rose 31.3% to close at $6.71. InMed recently reported a net loss of $33.17 per share for fiscal 22.
- AN2 Therapeutics, Inc. ANTX gained 31.1% to close at $15.50.
- FingerMotion, Inc. FNGR up 30.3% to close at $1.0592 after rising around 20% on Monday.
- Intelligent Living Application Group Inc. ILAG up 28.4% to close at $2.62 after gaining over 11% on Monday.
- Harrow Health, Inc. HROW rose 27.9% to $9.73 after the company announced that the FDA approved IHEEZO 3% for ocular surface anesthesia.
- Presto Automation, Inc. PRST rose 24% to close at $2.69.
- Equillium, Inc. equalizer rose 22.8% to close at $2.37. Equillium announced preliminary results from the Type B portion of the EQUALIZE study evaluating itolizumab in patients with lupus nephritis (LN).
- Lion Group Holding Ltd. LGHL rose 22.8% to close…
